Precision Medicine in Clinical Practice: Targeted Therapies and Diagnostics

EDURISE

Final Assessment: Integrating Precision Tools into Clinical Workflow

Included in course price

• Intro 01:03

  • 1: Precision Medicine Preview 01:03

• Video Material 2:04:49

  • 2: Module 1 Foundations of Precision Medicine 21:24
  • 3: Module 2 Advanced Genomic Analysis 21:31
  • 4: Module 3 Translational Bioinformatics 22:59
  • 5: Module 4 Biomarker Discovery and Validation 20:38
  • 6: Module 5 Precision Oncology 20:22
  • 7: Module 6 Personalized Cardiovascular Medicine part 1 17:55

• PDF Material 1:06:00

  • 8: Module 1_ Foundations of Precision Medicine 10:00
  • 9: Module 2_ Advanced Genomic Analysis 10:00
  • 10: Module 3_ Translational Bioinformatics 11:00
  • 11: Module 4_ Biomarker Discovery and Validation 10:00
  • 12: Module 5_ Precision Oncology 10:00
  • 13: Module 6_ Personalized Cardiovascular Medicine 10:00
  • 14: MCQs 05:00
  • 15: Precision Case Report: Genomic Interpretation & Personalized Treatment Plan -

• Bonus Material 22:07

  • 16: Podcast 19:07
  • 17: MCQs 03:00

The Precision Medicine – Certified Professional Program is an advanced, interdisciplinary course designed to equip healthcare professionals, researchers, and biomedical analysts with the knowledge and technical skills to deliver personalized, data-informed patient care. Spanning six comprehensive modules, this program offers a deep dive into the scientific foundations, bioinformatics tools, clinical applications, and ethical frameworks that define the field of precision medicine today.

Module 1: Foundations of Precision Medicine

This foundational module introduces the evolution and core principles of precision medicine, highlighting its growing impact on patient care and public health. Learners explore the transition from population-based healthcare to individualized diagnostics and treatment, considering how environmental, genetic, and lifestyle factors intersect to shape disease risk and therapeutic outcomes.

The module covers key terminology, the history of genomic medicine, and the role of big data in modern healthcare delivery. Learners examine case studies illustrating how stratified care improves outcomes across diverse patient groups and evaluate the infrastructure required for precision medicine programs, including biobanking, electronic health records (EHR), and high-throughput sequencing platforms. The module concludes by addressing global initiatives like the All of Us Research Program and the 100,000 Genomes Project, setting the stage for deeper exploration in subsequent modules.

Module 2: Advanced Genomic Analysis

In this module, learners develop advanced knowledge of human genomics and the bioinformatic techniques used to analyze DNA and RNA sequencing data. The curriculum begins with a review of genome structure, gene expression regulation, and variation types (SNPs, indels, CNVs). Learners then progress to technical aspects of sequencing, focusing on platforms such as Illumina and Oxford Nanopore.

Students gain hands-on experience with analytical pipelines used to process sequencing data, including quality control, read alignment, variant calling, and annotation. The use of tools such as GATK, SAMtools, and VEP is demonstrated through real genomic datasets. Clinical interpretation of variants is taught using ACMG guidelines, enabling learners to distinguish pathogenic mutations from benign polymorphisms and to understand the implications of variants of uncertain significance (VUS). This module also emphasizes the importance of data curation, reproducibility, and collaborative data-sharing in genomic research.

Module 3: Translational Bioinformatics

This module focuses on the integration of multi-modal health data—including genomics, transcriptomics, clinical phenotypes, and EHRs—into actionable clinical insights. Learners explore the principles of translational bioinformatics and how computational models can support precision medicine by identifying biomarkers, predicting drug responses, and stratifying patients.

Through case-based exercises, participants analyze real datasets to identify genotype-phenotype correlations and build predictive models using machine learning techniques. Emphasis is placed on the use of databases and resources such as dbSNP, ClinVar, COSMIC, OMIM, and TCGA. The module also explores how artificial intelligence (AI) and natural language processing (NLP) are being applied to mine biomedical literature, clinical records, and genomic annotations for precision therapy recommendations. Ethical considerations related to data security and algorithmic bias are also addressed.

Module 4: Biomarker Discovery and Validation

Biomarkers are critical for early detection, treatment selection, and disease monitoring in precision medicine. This module offers a comprehensive overview of how biomarkers are identified, validated, and implemented in clinical practice. Learners study different classes of biomarkers, including genetic, proteomic, metabolomic, and imaging-based indicators.

The module walks students through the biomarker development pipeline—from discovery using high-throughput technologies to analytical validation, clinical qualification, and regulatory approval. Key topics include sensitivity and specificity, ROC curves, surrogate endpoints, and the role of biomarkers in companion diagnostics. Case studies illustrate how biomarkers are used to guide treatment decisions in cancer, autoimmune diseases, and neurological disorders. The module also covers the challenges of biomarker reproducibility, standardization, and cross-population applicability.

Module 5: Precision Oncology

Precision oncology is one of the most mature applications of personalized medicine. This module delves into how molecular profiling of tumors guides targeted therapies and immunotherapies. Learners examine the genetic drivers of common cancers and how these mutations inform drug response.

Techniques such as liquid biopsy, next-generation sequencing (NGS) of tumor DNA, and RNA-based expression profiling are covered. Students explore the mechanisms of action for various targeted therapies—including EGFR inhibitors, BRAF inhibitors, and checkpoint inhibitors—and understand how tumor mutational burden, microsatellite instability, and PD-L1 expression influence treatment choice.

Learners are introduced to the use of comprehensive genomic panels, tumor boards, and clinical decision-support systems that match patients to appropriate therapies or clinical trials. Resistance mechanisms and clonal evolution are also addressed to prepare students for managing relapsed or refractory disease. Real-world cases demonstrate the application of precision medicine in breast, lung, colorectal, and hematologic cancers.

Module 6: Personalized Cardiovascular Medicine

This module focuses on how genetic and molecular data are used to predict, diagnose, and manage cardiovascular diseases. Learners study common genetic variants associated with conditions such as familial hypercholesterolemia, cardiomyopathies, arrhythmias, and congenital heart defects.

The curriculum emphasizes the use of polygenic risk scores (PRS), pharmacogenomics, and wearable technology in cardiovascular care. Students learn how genetic testing can inform decisions about statin therapy, antiplatelet drugs, and anticoagulants like warfarin. The integration of lifestyle data, digital biomarkers, and mobile health monitoring for personalized risk assessment and prevention strategies is also explored.

Students analyze population-level datasets to examine how environmental factors, social determinants of health, and behavioral interventions intersect with genomics in cardiovascular risk prediction. This module highlights the need for precision prevention strategies and the expansion of genomic screening in cardiology practice.

Learning Outcomes

By the end of this program, participants will be able to:

• Interpret genomic data using bioinformatics pipelines and variant classification guidelines.

• Design patient-specific treatment plans using pharmacogenomics and molecular profiling.

• Analyze and apply multi-omics data for diagnosis, prognosis, and therapy selection.

• Identify and evaluate clinically relevant biomarkers for various disease states.

• Apply precision medicine principles to oncology, cardiology, and rare diseases.

• Navigate ethical issues around genomic privacy, consent, and equitable access.

• Communicate complex genetic findings effectively to clinicians and patients.

The Precision Medicine – Certified Professional Program is ideal for professionals and students aiming to apply cutting-edge genomic and data-driven approaches in healthcare, biomedical research, and clinical practice. This course is especially suited for:

• Medical Doctors and Clinicians – seeking to integrate genomic data and targeted therapies into patient care.

• Genetic Counselors and Clinical Geneticists – aiming to deepen their understanding of variant interpretation and risk assessment.

• Biomedical Researchers and Lab Scientists – involved in biomarker discovery, translational medicine, or clinical trials.

• Bioinformaticians and Data Scientists – transitioning into healthcare or refining their skills in multi-omics data analysis.

• Pharmacists and Pharmacogenomics Specialists – focused on optimizing drug therapy based on genetic profiles.

• Public Health and Policy Professionals – engaged in personalized healthcare strategy, ethics, and accessibility.

• Graduate Students in Medicine, Biology, or Biotechnology – preparing for careers in genomic medicine, oncology, or precision diagnostics.

• Biotech and Pharma Professionals – working on personalized diagnostics, clinical decision tools, or molecular therapeutics.

Whether you're working in hospitals, diagnostic labs, research institutions, or biotech industries, this course empowers you to apply precision approaches that improve diagnosis, treatment, and prevention at an individual level.

Graduates can pursue roles such as Precision Medicine Specialist, Clinical Genomic Analyst, Bioinformatics Scientist, or Pharmacogenomics Consultant. In the UK, salaries range from £35,000–£50,000 for entry-level roles, rising to £60,000–£85,000+ in senior positions within hospitals, biotech, pharma, or research institutions.

There are currently no Q&As for this course. Be the first to ask a question.